134 related articles for article (PubMed ID: 37573161)
21. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
[TBL] [Abstract][Full Text] [Related]
22. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
23. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions.
Wrone-Smith T; Bergstrom J; Quevedo ME; Reddy V; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1999 Jan; 19(1):53-67. PubMed ID: 9890376
[TBL] [Abstract][Full Text] [Related]
25. Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma.
Dadfarnia T; Mohammed BS; Eltorky MA
Ann Diagn Pathol; 2012 Jun; 16(3):171-6. PubMed ID: 22197541
[TBL] [Abstract][Full Text] [Related]
26. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
27. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
28. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
29. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
31. [ASSOCIATION OF SKIN PHOTOTYPE AND UV EXPOSURE WITH EXPRESSION OF HER RECEPTORS, Ki67 AND p53 IN PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA].
Drvar DL; Lipozenčić J; Mokos ZB; Ilić I; Knežević F
Acta Med Croatica; 2015; 69(5):431-8. PubMed ID: 29087088
[TBL] [Abstract][Full Text] [Related]
32. Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study.
Bowen AR; Burt L; Boucher K; Tristani-Firouzi P; Florell SR
J Cutan Pathol; 2012 Feb; 39(2):243-50. PubMed ID: 22236162
[TBL] [Abstract][Full Text] [Related]
33. Low detection rate of human papillomavirus in patients with cutaneous squamous cell carcinoma and keratoacanthoma.
Baek YS; Kim YC; Kim KE; Jeon J; Kim A; Song HJ; Kim C
Eur J Dermatol; 2022 Sep; 32(5):577-583. PubMed ID: 36468731
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression.
Pilch H; Weiss J; Heubner C; Heine M
J Cutan Pathol; 1994 Dec; 21(6):507-13. PubMed ID: 7699117
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
Biesterfeld S; Josef J
Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
[TBL] [Abstract][Full Text] [Related]
36. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
37. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Putti TC; Teh M; Lee YS
Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
[TBL] [Abstract][Full Text] [Related]
38. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.
Leblebici C; Pasaoglu E; Kelten C; Darakci S; Dursun N
Oncol Lett; 2017 Apr; 13(4):2539-2548. PubMed ID: 28454431
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1).
Matsuta M; Kimura S; Kosegawa G; Kon S; Matsuta M
J Dermatol; 1996 Mar; 23(3):147-52. PubMed ID: 8935623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]